We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
CDER pushed back the Prescription Drug User Fee Act (PDUFA) action date for Mallinckrodt’s Exalgo extended-release tables until Feb. 22 to review
new information.